1 |
0.5% marcaine |
- |
- |
- |
- |
070 1件: 70 💬 |
2 |
0.9% saline |
- |
- |
- |
- |
070 1件: 70 💬 |
3 |
0002-8971 |
- |
- |
- |
- |
070 1件: 70 💬 |
4 |
1mg/kg/hr txa intravenous infusion till the last suture |
- |
- |
- |
- |
070 1件: 70 💬 |
5 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
6 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
7 |
Adjunctive analgesics |
- |
- |
- |
- |
070 1件: 70 💬 |
8 |
Adjunctive anti-depressants |
- |
- |
- |
- |
070 1件: 70 💬 |
9 |
Ak1320 ms |
- |
- |
- |
- |
070 1件: 70 💬 |
10 |
Allogen-li |
- |
- |
- |
- |
070 1件: 70 💬 |
11 |
Alprostadil |
Alprostadil |
2件: D00180 D00180, D02705 D02705 💬 |
PTGER1 1件: PTGER1 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 2件: 51, 70 💬 |
12 |
Amino acids |
Amino acids |
- |
- |
- |
070 3件: 70, 240, 298 💬 |
13 |
Aminocaproic acid |
Aminocaproic acid |
1件: D00160 D00160 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 1件: 70 💬 |
14 |
Amniotic fluid allograft |
- |
- |
- |
- |
070 1件: 70 💬 |
15 |
Apple |
Apple |
- |
- |
- |
070 1件: 70 💬 |
16 |
Bilateral transforaminal epidural steroid injections |
- |
- |
- |
- |
070 1件: 70 💬 |
17 |
Bone marrow concentrate |
- |
- |
- |
- |
070 1件: 70 💬 |
18 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
19 |
Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
070 1件: 70 💬 |
20 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
21 |
Bupivacaïne hcl 0,125% / sufentanil 50 µg flacon à 50 ml |
Sufentanil |
2件: D00845 D00845, D05938 D05938 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
22 |
Buprenorphine |
Buprenorphine |
2件: D00836 D00836, D07132 D07132 💬 |
OPRK1 2件: OPRK1, OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 2件: 46, 70 💬 |
23 |
Caudal epidural injection |
- |
- |
- |
- |
070 1件: 70 💬 |
24 |
Caudal epidural injection with celestone |
- |
- |
- |
- |
070 1件: 70 💬 |
25 |
Caudal epidural injection with depomedrol |
- |
- |
- |
- |
070 1件: 70 💬 |
26 |
Caudal epidural injection with generic celestone |
- |
- |
- |
- |
070 1件: 70 💬 |
27 |
Celebrex 200mg capsule |
- |
- |
- |
- |
070 1件: 70 💬 |
28 |
Celecoxib |
Celecoxib |
1件: D00567 D00567 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
002 9件: 2 , 3 , 34, 46, 70, 89, 161, 171, 271 💬 |
29 |
Cilostazol |
Cilostazol |
1件: D01896 D01896 💬 |
PDE3A 3件: PDE3A, PDE3B, TBXA2R 💬 |
Apelin signaling pathway 14件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 2件: 51, 70 💬 |
30 |
Co |
- |
- |
- |
- |
006 5件: 6 , 13, 53, 70, 85 💬 |
31 |
Combination product: goldic serum |
- |
- |
- |
- |
070 1件: 70 💬 |
32 |
Control group |
- |
- |
- |
- |
002 3件: 2 , 46, 70 💬 |
33 |
Creatinine |
Creatinine |
1件: D03600 D03600 💬 |
- |
- |
002 4件: 2 , 46, 60, 70 💬 |
34 |
Darvocet |
- |
- |
- |
- |
070 1件: 70 💬 |
35 |
Decadron phosphate, injectable |
Phosphate ion |
- |
- |
- |
070 1件: 70 💬 |
36 |
Deksmedetomidiini |
- |
- |
- |
- |
070 1件: 70 💬 |
37 |
Demineralized bone matrix |
- |
- |
- |
- |
070 1件: 70 💬 |
38 |
Depomedrol |
- |
- |
- |
- |
070 1件: 70 💬 |
39 |
Device: apple watch and app |
Apple |
- |
- |
- |
070 1件: 70 💬 |
40 |
Device: bioactive glass-ceramic spacer |
- |
- |
- |
- |
070 1件: 70 💬 |
41 |
Device: cervical orthosis (co) |
- |
- |
- |
- |
070 1件: 70 💬 |
42 |
Device: interbody cage (peek) |
- |
- |
- |
- |
070 1件: 70 💬 |
43 |
Device: interbody cage (titanium) |
Titanium |
- |
- |
- |
070 1件: 70 💬 |
44 |
Device: mastergraft granules |
- |
- |
- |
- |
070 1件: 70 💬 |
45 |
Device: mild® (minimally invasive lumbar decompression) |
- |
- |
- |
- |
070 1件: 70 💬 |
46 |
Device: mri |
- |
- |
- |
- |
070 3件: 70, 85, 278 💬 |
47 |
Device: no orthosis |
- |
- |
- |
- |
070 1件: 70 💬 |
48 |
Device: philips intelivue mp70 monitor |
Methamidophos |
- |
- |
- |
070 1件: 70 💬 |
49 |
Device: pleth variability index (pvi) |
- |
- |
- |
- |
070 1件: 70 💬 |
50 |
Device: therm-apptm th, thermographic camera |
- |
- |
- |
- |
070 1件: 70 💬 |
51 |
Device: titanium cage |
Titanium |
- |
- |
- |
070 1件: 70 💬 |
52 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
53 |
Dexamethasone sodium phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 3件: 65, 70, 96 💬 |
54 |
Dexdor |
- |
- |
- |
- |
002 4件: 2 , 4 , 6 , 70 💬 |
55 |
Dexmedetomidine |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
56 |
Dexmedetomidine group |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
57 |
Dexmedetomidine hydrochloride |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
58 |
Dexmedetomidine with ropivacaine |
Dexmedetomidine |
4件: D00514 D00514, D01205 D01205, D04048 D04048, D08490 D08490 💬 |
ADRA2A 8件: ADRA2A, ADRA2B, ADRA2C, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
59 |
Dextrose |
Dextrose, unspecified form |
- |
- |
- |
056 4件: 56, 60, 65, 70 💬 |
60 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
61 |
Eaca |
Aminocaproic acid |
1件: D00160 D00160 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 1件: 70 💬 |
62 |
Epidural injection |
- |
- |
- |
- |
070 1件: 70 💬 |
63 |
Epidural local anesthetic injection |
- |
- |
- |
- |
070 1件: 70 💬 |
64 |
Epidural steroid injection |
- |
- |
- |
- |
070 1件: 70 💬 |
65 |
Epsilon-aminocaproic acid (eaca) |
Aminocaproic acid |
1件: D00160 D00160 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 1件: 70 💬 |
66 |
Erector spinae plane block (group e) |
- |
- |
- |
- |
070 1件: 70 💬 |
67 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
68 |
Esketamine |
Esketamine |
1件: D07283 D07283 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 3件: 2 , 4 , 70 💬 |
69 |
Esketamine hydrochloride |
Esketamine |
1件: D07283 D07283 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 1件: 70 💬 |
70 |
Fentanyl |
Fentanyl |
2件: D00320 D00320, D01399 D01399 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 4件: 46, 70, 215, 231 💬 |
71 |
Forsteo |
- |
- |
- |
- |
070 3件: 70, 235, 274 💬 |
72 |
Forteo |
- |
- |
- |
- |
070 1件: 70 💬 |
73 |
Gabapentin |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
74 |
Heparin |
Heparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
060 11件: 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317 💬 |
75 |
Herbal medicine |
- |
- |
- |
- |
070 1件: 70 💬 |
76 |
Hyaluronic acid |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
046 5件: 46, 53, 70, 226, 231 💬 |
77 |
Hydromorphone |
Hydromorphone |
2件: D00839 D00839, D08047 D08047 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
78 |
I-factor |
- |
- |
- |
- |
070 1件: 70 💬 |
79 |
Kenalog injectable product |
- |
- |
- |
- |
070 1件: 70 💬 |
80 |
Ketamine |
Ketamine |
2件: D00711 D00711, D08098 D08098 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 5件: 13, 70, 113, 156, 215 💬 |
81 |
Ketanest |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
82 |
Ketanest-s |
- |
- |
- |
- |
002 3件: 2 , 4 , 70 💬 |
83 |
Ketorolac |
Ketorolac |
2件: D00813 D00813, D08104 D08104 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
070 2件: 70, 226 💬 |
84 |
Limaprost |
Limaprost |
1件: D02722 D02722 💬 |
PTGER1 1件: PTGER1 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
070 1件: 70 💬 |
85 |
Liposomal bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 3件: 51, 70, 96 💬 |
86 |
Lumbar interbody fusion with autograft |
- |
- |
- |
- |
070 1件: 70 💬 |
87 |
Lumbar interbody fusion with neofuse |
- |
- |
- |
- |
070 1件: 70 💬 |
88 |
Magnesium |
Magnesium |
- |
- |
- |
006 16件: 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
89 |
Magnesium with ropivacaine |
Magnesium |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 1件: 70 💬 |
90 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
91 |
Mirogabalin |
Mirogabalin |
1件: D11203 D11203 💬 |
CACNA2D1 2件: CACNA2D1, CACNA2D2 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 1件: 70 💬 |
92 |
Misoprostol |
Misoprostol |
1件: D00419 D00419 💬 |
PTGER2 3件: PTGER2, PTGER3, PTGER4 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway |
046 3件: 46, 70, 271 💬 |
93 |
Modal |
- |
- |
- |
- |
002 5件: 2 , 6 , 17, 46, 70 💬 |
94 |
Modified-thoracolumbar interfascial plane block |
- |
- |
- |
- |
070 1件: 70 💬 |
95 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
96 |
Morphine |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 5件: 36, 46, 70, 85, 86 💬 |
97 |
Morphine pca |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
98 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
2件: D00217 D00217, D00332 D00332 💬 |
CACNA2D1 7件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 1件: 70 💬 |
99 |
Multi-modal pain management [fentanyl] |
Fentanyl |
2件: D00320 D00320, D01399 D01399 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
100 |
Multi-modal pain management [intravenous ketamine] |
Ketamine |
2件: D00711 D00711, D08098 D08098 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 1件: 70 💬 |
101 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
102 |
Neofuse |
- |
- |
- |
- |
070 1件: 70 💬 |
103 |
Nicardipine |
Nicardipine |
2件: D00617 D00617, D08270 D08270 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 2件: 70, 86 💬 |
104 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
105 |
Ns-304 |
- |
- |
- |
- |
070 3件: 70, 86, 88 💬 |
106 |
Ns-304 placebo |
- |
- |
- |
- |
070 2件: 70, 88 💬 |
107 |
Nsaids |
- |
- |
- |
- |
046 4件: 46, 70, 107, 271 💬 |
108 |
Nucel |
- |
- |
- |
- |
070 1件: 70 💬 |
109 |
Oksikodoni |
- |
- |
- |
- |
070 1件: 70 💬 |
110 |
Opana |
- |
- |
- |
- |
070 1件: 70 💬 |
111 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
112 |
Other: conventional pca mode |
- |
- |
- |
- |
070 1件: 70 💬 |
113 |
Other: epiduroscopy |
- |
- |
- |
- |
070 1件: 70 💬 |
114 |
Other: group exercise: community setting |
- |
- |
- |
- |
070 1件: 70 💬 |
115 |
Other: individualized exercises: clinical setting |
- |
- |
- |
- |
070 1件: 70 💬 |
116 |
Other: joint mobilizations (spine, sacroiliac, hip) |
- |
- |
- |
- |
070 1件: 70 💬 |
117 |
Other: no intervention |
- |
- |
- |
- |
070 1件: 70 💬 |
118 |
Other: optimizing basal infusion (b.i) |
- |
- |
- |
- |
070 1件: 70 💬 |
119 |
Other: other intervention(s) |
- |
- |
- |
- |
070 1件: 70 💬 |
120 |
Other: physical therapy |
- |
- |
- |
- |
006 2件: 6 , 70 💬 |
121 |
Oxanest |
- |
- |
- |
- |
070 1件: 70 💬 |
122 |
Oxycodone |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 7件: 6 , 13, 46, 70, 226, 231, 298 💬 |
123 |
Oxycodone hydrochloride |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 4件: 6 , 70, 226, 298 💬 |
124 |
Oxycodone orion |
Oxycodone |
3件: D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
070 1件: 70 💬 |
125 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
126 |
Parathyroid hormone |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 2件: 70, 235 💬 |
127 |
Pca |
- |
- |
- |
- |
046 2件: 46, 70 💬 |
128 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
129 |
Plf with neofuse |
- |
- |
- |
- |
070 1件: 70 💬 |
130 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 2件: 51, 70 💬 |
131 |
Predinose oral |
- |
- |
- |
- |
070 1件: 70 💬 |
132 |
Pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 5件: 13, 36, 46, 70, 298 💬 |
133 |
Pregabalin 75mg |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 1件: 70 💬 |
134 |
Procedure: acupuncture |
- |
- |
- |
- |
046 2件: 46, 70 💬 |
135 |
Procedure: allograft |
- |
- |
- |
- |
070 1件: 70 💬 |
136 |
Procedure: bee venom pharmacopuncture |
- |
- |
- |
- |
070 1件: 70 💬 |
137 |
Procedure: chuna manipulation |
- |
- |
- |
- |
070 1件: 70 💬 |
138 |
Procedure: chuna manual medicine |
- |
- |
- |
- |
070 1件: 70 💬 |
139 |
Procedure: cupping |
- |
- |
- |
- |
070 1件: 70 💬 |
140 |
Procedure: electroacupuncture |
- |
- |
- |
- |
006 2件: 6 , 70 💬 |
141 |
Procedure: epidural local anesthetic injection |
- |
- |
- |
- |
070 1件: 70 💬 |
142 |
Procedure: epidural steroid (dexamethasone) injection |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
143 |
Procedure: epidural steroid injection |
- |
- |
- |
- |
070 1件: 70 💬 |
144 |
Procedure: epidural steroid with local anesthetic injection |
- |
- |
- |
- |
070 1件: 70 💬 |
145 |
Procedure: lumbar epidural injection |
- |
- |
- |
- |
070 1件: 70 💬 |
146 |
Procedure: lumbar interlaminar epidural steroid injection |
- |
- |
- |
- |
070 1件: 70 💬 |
147 |
Procedure: manual therapy |
- |
- |
- |
- |
070 1件: 70 💬 |
148 |
Procedure: mild procedure |
- |
- |
- |
- |
070 1件: 70 💬 |
149 |
Procedure: other intervention(s) |
- |
- |
- |
- |
070 1件: 70 💬 |
150 |
Procedure: percutaneous lumbar decompression |
- |
- |
- |
- |
070 1件: 70 💬 |
151 |
Procedure: pharmacopuncture |
- |
- |
- |
- |
070 1件: 70 💬 |
152 |
Procedure: plf with autograft |
- |
- |
- |
- |
070 1件: 70 💬 |
153 |
Procedure: posterolateral spinal fusion with instrumentation |
- |
- |
- |
- |
070 1件: 70 💬 |
154 |
Prolotherapy solution of 20% dextrose |
Dextrose, unspecified form |
- |
- |
- |
070 1件: 70 💬 |
155 |
Remifentanil |
Remifentanil |
2件: D01177 D01177, D08473 D08473 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
006 2件: 6 , 70 💬 |
156 |
Rhpth |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 3件: 70, 235, 326 💬 |
157 |
Rhpth (1-34) |
Parathyroid hormone |
1件: D05364 D05364 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 1件: 70 💬 |
158 |
Ropivacaine |
Ropivacaine |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
036 3件: 36, 46, 70 💬 |
159 |
Ropivacaine plus normal saline |
Ropivacaine |
2件: D04048 D04048, D08490 D08490 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
070 1件: 70 💬 |
160 |
S-ketamine |
Esketamine |
3件: D00711 D00711, D07283 D07283, D08098 D08098 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
070 1件: 70 💬 |
161 |
S-ketamine & midazolam |
Esketamine |
6件: D00550 D00550, D00696 D00696, D00711 D00711, D05028 D05028, D07283 D07283, D08098 D08098 💬 |
GABRA1 21件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 25件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
070 1件: 70 💬 |
162 |
Selexipag |
Selexipag |
1件: D09994 D09994 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 5件: 51, 70, 84, 86, 88 💬 |
163 |
Standard analgesia use [fentanyl] |
Fentanyl |
2件: D00320 D00320, D01399 D01399 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
164 |
Standard analgesia use [hydromorphone] |
Hydromorphone |
2件: D00839 D00839, D08047 D08047 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
165 |
Standard analgesia use [oxygen] |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
070 1件: 70 💬 |
166 |
Standard analgesia use [volatile anesthesia] |
- |
- |
- |
- |
070 1件: 70 💬 |
167 |
Steroid injections |
- |
- |
- |
- |
070 1件: 70 💬 |
168 |
Sufentanil |
Sufentanil |
2件: D00845 D00845, D05938 D05938 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
070 2件: 70, 280 💬 |
169 |
Sugar pill |
- |
- |
- |
- |
005 8件: 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
170 |
Teicoplanin |
Teicoplanin |
1件: D02142 D02142 💬 |
- |
- |
070 2件: 70, 299 💬 |
171 |
Teriparatide |
Teriparatide |
1件: D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
046 6件: 46, 68, 70, 71, 235, 274 💬 |
172 |
Teriparatide [rdna origin] contains recombinant human parathyroid hormone (1-34) |
Parathyroid hormone |
2件: D05364 D05364, D06078 D06078 💬 |
PTH1R 2件: PTH1R, PTH2R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
070 1件: 70 💬 |
173 |
Titanium |
Titanium |
- |
- |
- |
069 2件: 69, 70 💬 |
174 |
Tramadol |
Tramadol |
2件: D01355 D01355, D08623 D08623 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 5件: 46, 70, 78, 226, 271 💬 |
175 |
Tramadol with ropivacaine |
Ropivacaine |
4件: D01355 D01355, D04048 D04048, D08490 D08490, D08623 D08623 💬 |
OPRM1 6件: OPRM1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 6件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction |
070 1件: 70 💬 |
176 |
Tranexamic acid |
Tranexamic acid |
1件: D01136 D01136 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
046 5件: 46, 70, 215, 227, 288 💬 |
177 |
Tranexamic acid 100 mg/ml |
Tranexamic acid |
1件: D01136 D01136 💬 |
PLG 1件: PLG 💬 |
Complement and coagulation cascades 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection |
070 1件: 70 💬 |
178 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
3件: D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 6件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
179 |
Transforaminal epidural injection |
- |
- |
- |
- |
070 1件: 70 💬 |
180 |
Triamcinolone |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬 |
181 |
Triamcinolone acetonide and normal saline solution |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
070 1件: 70 💬 |
182 |
Tylenol |
- |
- |
- |
- |
070 1件: 70 💬 |
183 |
Vancomycin |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
046 7件: 46, 70, 94, 96, 97, 296, 299 💬 |
184 |
Vivigen cellular bone matrix |
- |
- |
- |
- |
070 1件: 70 💬 |
185 |
With u-vanco (vancomycin hydrochloride) |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
070 1件: 70 💬 |
186 |
Without u-vanco (vancomycin hydrochloride) |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
070 1件: 70 💬 |
187 |
Wound topically irrigated with 500mg txa |
- |
- |
- |
- |
070 1件: 70 💬 |
188 |
Xylocaine |
- |
- |
- |
- |
070 1件: 70 💬 |